According to the new market research report “Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region – Global Forecast to 2023”, published by MarketsandMarkets™, The global cell therapy technologies market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period.
Don’t miss out on business opportunities in Cell Therapy Technologies Market.
Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this cell therapy technologies market.
To know about the assumptions considered for the study, download the pdf brochure
Browse and in-depth TOC on ” Cell Therapy Technologies Market ”
75 – Tables
30 – Figures
116 – Pages
Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213334978
Cell processing segment to witness the highest growth during the forecast period
Based on process, the cell therapy technologies market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest market share in 2018 and is projected to witness the highest CAGR during the forecasted period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.
Key Market Players
Key players in this cell therapy technologies market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
